Inflammatory pathways

Contributions to Nephrology

Volumn 170, Issue , 2011, Pages 113-123

  Navarro González, Juan F ^a   Mora Fernández, Carmen ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; CYTOKINE; PROTEIN KINASE C; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; DIABETIC NEPHROPATHY; HUMAN; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PHYSIOLOGY;

ALDEHYDE REDUCTASE; ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OXIDATIVE STRESS; PROTEIN KINASE C;

EID: 79959245234     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000325646     Document Type: Article

References (30)

1. Atkins RC: The epidemiology of chronic kidney disease. Kidney Int 2005;67(suppl 94):S14-S18.
2. Pickup J, Crook M: Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998;41:1241-1248. (Pubitemid 28449093)
3. Temelkova-Kurktschiev T, Henkel E, Koelher C, Karrei K, Hanefield M: Subclinical inflammation in newly detected type II diabetes and impaired glucose tolerance. Diabetologia 2002;45:151. (Pubitemid 34118556)
4. Pickup JC, Chusney GC, Thomas SM, Burt D: Plasma interleukin-6, tumor necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000;67:291-300. (Pubitemid 30413937)
5. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334. (Pubitemid 32656163)
6. Spranger J, Kroke A, Mohlig M, Hoffman K, Bergman MM, Ristow M, Boeing H, Pfeiffer AFH: Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC) Postsdam study. Diabetes 2003;52:812-817. (Pubitemid 36323590)
7. Ramana KV, Friedrich B, Tammali R, West MB, Bhatnagar A, Srivastava SK: Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes 2005;54: 818-829. (Pubitemid 40322087)
8. Ramana KV, Srivastrava SK: Aldose reductase: A novel therapeutic target for inflammatory pathologies. Int J Biochem Cell Biol 2010;42:17-20.
9. Das EN, King GL: The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 2007;55:498-510. (Pubitemid 46962309)
10. Way KJ, Katai N, King GL: Protein kinase C and the development of diabetic vascular complications. Diabetes Med 2001;18: 945-959. (Pubitemid 34042930)
11. Bierhaus A, Nawroth PP: Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009;52:2251-2263.
12. Forbes JM, Coughlan MT, Cooper ME: Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008;57: 1446-1454.
13. Giacco F, Brownlee M: Oxidative stress and diabetic complications. Circ Res 2010;107:1058-1070.
14. Vasavada N, Agarwal R: Role of oxidative stress in diabetic nephropathy. Adv Chronic Kidney Dis 2005;12:146-154. (Pubitemid 40488997)
15. Chiarelli F, Gaspari S, Marcovecchio ML: Role of growth factors in diabetic kidney disease. Horm Metab Res 2009;41:585-593.
16. Pohlers D, Brenmoehl J, Loffler I, Muller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G: TGF-beta and fibrosis in different organs -molecular pathway imprints. Biochim Biophys Acta 2009; 1792:746-756.
17. Qi W, Chen X, Poronink P, Pollock CA: Transforming growth factor-beta/connective tissue growth factor axis in the kidney. Int J Biochem Cell Biol 2008;40:9-13. (Pubitemid 350064576)
18. Ziyadeh FN, Wolf G: Pathogenesis of the podocytopatia and proteinuria in diabetic glomerulopathy. Curr Diab Rev 2008;4: 39-45. (Pubitemid 351210971)
19. Schmidt-Ott KM: Unraveling the role of connective tissue growth factor in diabetic nephropathy. Kidney Int 2008;73:375-376. (Pubitemid 351186281)
20. Schrijvers BF, Flyvbjerg A, De Vriese AS: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004;65:2003-2007.
21. Nakagawa T: Uncoupling of VEGF with NO as a mechanism for diabetic nephropathy. Diabetes Res Clin Pract 2008;13(suppl 1): S67-S69.
22. Ruster C, Wolf G: The role of chemokines and chemokine receptors in diabetic nephropathy. Front Biosci 2008;13:944-955. (Pubitemid 351594739)
23. Chow F, Nikolic-Paterson DJ, Ozols E, Atkins RC, Rollin BJ, Tesch GH: Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006;69:73-80. (Pubitemid 43117741)
24. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH: Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 2005;16:1711-1722. (Pubitemid 41716477)
25. Stehouwer CDA, Gall MA, Twisk JWR, Knudsen E, Emeis JJ, Parving HH : Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death. Diabetes 2002;51:1157-1165. (Pubitemid 34438363)
26. Navarro-Gonzalez JF, Mora-Fernandez C: The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008;19:433-442. (Pubitemid 351355386)
27. Navarro JF, Mora-Fernandez C: The role of TNF-a in diabetic nephropathy: Pathogenic and therapeutic implications. Cytokine Growth Factor Rev 2006;17:441-450. (Pubitemid 44803222)
28. Navarro-Gonzalez JF, Jarque A, Muros M, Mora C, Garcia J: Tumor necrosis factor-a as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev 2009;20: 165-173.
29. Kalantarinia K, Awas AS, Siragy HM: Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. Kidney Int 2003;64:1208-1213. (Pubitemid 37153785)
30. Navarro JF, Mora C, Muros M, Garcia J: Urinary tumor necrosis factor-a excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Nephrol Dial Transplant 2006;21:3428-3434. (Pubitemid 44817091)